The anterior cruciate ligament (ACL) serves as a vital stabilizer for the human knee, yet it is one of the most injured ligaments in the body. Function of the knee is restored through reconstruction and physical therapy, but long term functional deficits persist in some individuals. To better understand the influence of post rehabilitation outcomes on dynamic balance performance, this study evaluated bilateral differences in strength and stability in 11 participants who have rehabilitated from an ACL reconstruction or repair. The Y-Balance Test and an isokinetic strength assessment using the Biodex dynamometer were used to measure dynamic knee stability and strength, respectively. No significant differences were found in the strength test measurements. However, side to side differences in Y-Balance Test composite score (-2.8±3.1%, p = 0.014), maximal anterior reach (-2.8±2.4 cm, p = 0.01), and posterolateral reach (-2.75±3.5 cm, p = 0.02) were found to be significantly impaired in participants' involved limbs compared to the uninvolved limbs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033496PMC
http://dx.doi.org/10.70252/MUNO4563DOI Listing

Publication Analysis

Top Keywords

strength stability
8
anterior cruciate
8
cruciate ligament
8
differences strength
8
y-balance test
8
strength
5
stability analysis
4
analysis rehabilitated
4
rehabilitated anterior
4
ligament individuals
4

Similar Publications

Porous silicon (pSi) has gained substantial attention as a versatile material for various biomedical applications due to its unique structural and functional properties. Initially used as a semiconductor material, pSi has transitioned into a bioactive platform, enabling its use in drug delivery systems, biosensing, tissue engineering scaffolds, and implantable devices. This review explores recent advancements in macrostructural pSi, emphasizing its biocompatibility, biodegradability, high surface area, and tunable properties.

View Article and Find Full Text PDF

Evaluation of biobased materials in the development of polymeric membranes for water capture and purification.

Int J Biol Macromol

January 2025

Departamento de Ingeniería Química, Facultad de Química, Universidad de Sevilla, 41012 Sevilla, Spain.

The current study addresses the pressing issue of unsustainable water management, particularly in regions experiencing high water stress. It focuses on examining the viability of polymeric membranes composed of biobased materials, mainly chitosan, for various sustainable water management solutions. The membranes evaluated in the study were blends of PVC with either chitosan-silica or charcoal-silica, designed to enhance their functionality and performance.

View Article and Find Full Text PDF

Synchronization stability of epileptic brain network with higher-order interactions.

Chaos

January 2025

Beijing Institute of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

Generally, epilepsy is considered as abnormally enhanced neuronal excitability and synchronization. So far, previous studies on the synchronization of epileptic brain networks mainly focused on the synchronization strength, but the synchronization stability has not yet been explored as deserved. In this paper, we propose a novel idea to construct a hypergraph brain network (HGBN) based on phase synchronization.

View Article and Find Full Text PDF

Noncovalent interactions are present in numerous synthetic and biological systems, playing an essential role in vital processes for life such as stabilization of proteins' structures or reversible binding in substrate-receptor complexes. Their study is relevant, but it presents challenges due to its inherent weak nature. In this context, molecular balances (MBs) are one of the most efficient physical organic chemistry tools to quantify noncovalent interactions, bringing beneficial knowledge regarding their nature and strength.

View Article and Find Full Text PDF

Mutations in connexin 32 (Cx32) are a common cause of Charcot-Marie-Tooth 1X (CMT1X) disease, an inherited peripheral neuropathy characterized by progressive neuromuscular weakness and demyelination. There are no approved pharmacologic therapies for CMT1X, and identifying new treatments that slow the onset and severity of neuromuscular decline may aid disease management. Cemdomespib is an orally bioavailable small molecule that improved demyelination and neuromuscular junction (NMJ) morphology in mice lacking Cx32 expression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!